Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines

被引：119

作者：

Trotter, Caroline L. ^{[1
]}

Ramsay, Mary E. ^{[1
]}

机构：

[1] Hlth Protect Agcy, Immunizat Dept, Ctr Infect, London NW9 5EQ, England

来源：

FEMS MICROBIOLOGY REVIEWS | 2007年 / 31卷 / 01期

关键词：

meningococcal disease; vaccine; epidemiology; Europe;

D O I：

10.1111/j.1574-6976.2006.00053.x

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

At the end of 2005, six European countries had implemented public immunization campaigns with serogroup C conjugate vaccines, and all had experienced substantial declines in the incidence of serogroup C disease. A quadrivalent ACWY meningococcal vaccine is in use in the USA, but serogroup A is extremely rare in Europe and serogroups Y and W135 are infrequent causes of disease. This paper outlines recommendations on the use of conjugate vaccines in Europe based on the experience with meningococcal C conjugate (MCC) vaccines so far.

引用

页码：101 / 107

页数：7

共 39 条

[1] Increasing incidence of meningococcal disease in Spain associated with a new variant of serogroup C [J].

S. Berrón ;

L. De La Fuente ;

E. Martín ;

J. A. Vázquez .

European Journal of Clinical Microbiology and Infectious Diseases, 1998, 17 (2) :85-89

[2] Epidemiology of nasopharyngeal carriage of Neisseria meningitidis in healthy Dutch children [J].

Bogaert, D ;

Hermans, PWM ;

Boelens, H ;

Sluijter, M ;

Luijendijk, A ;

Rümke, HC ;

Koppen, S ;

van Belkum, A ;

de Groot, R ;

Verbrugh, HA .

CLINICAL INFECTIOUS DISEASES, 2005, 40 (06) :899-902

[3] Neisseria meningitidis group B correlates of protection and assay standardization -: International meeting report Emory University, Atlanta, Georgia, United States, 16-17 march 2005 [J].

Borrow, R. ;

Carlone, G. M. ;

Rosenstein, N. ;

Plikaytis, B. ;

Blake, M. ;

Feavers, I. ;

Martin, D. ;

Zollinger, W. ;

Robbins, J. ;

Aaberge, I. ;

Granoff, D. M. ;

Miller, E. ;

van Alphen, L. ;

Poolman, J. ;

Rappuoli, R. ;

Danzig, L. ;

Hackell, J. ;

Danve, B. ;

Caulfield, M. ;

Lambert, S. ;

Stephens, D. .

VACCINE, 2006, 24 (24) :5093-5107

[4] Combination vaccine against invasive meningococcal B and pneumococcal infections -: Potential epidemiological and economic impact in The Netherlands [J].

Bos, JM ;

Rümke, HC ;

Welte, R ;

Spanjaard, L ;

van Alphen, L ;

Postma, MJ .

PHARMACOECONOMICS, 2006, 24 (02) :141-153

[5] Multilocus sequence typing for global surveillance of meningococcal disease [J].

Brehony, Carina ;

Jolley, Keith A. ;

Maiden, Martin C. J. .

FEMS MICROBIOLOGY REVIEWS, 2007, 31 (01) :15-26

[6]

Cano R, 2004, Euro Surveill, V9, P5, DOI 10.2807/esm.09.07.00474-en

[7] Protection from routine vaccination at the age of 14 months with meningococcal serogroup C conjugate vaccine in the Netherlands [J].

de Greeff, SC ;

de Melker, HE ;

Spanjaard, L ;

Schouls, LM ;

van DerEnde, A .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2006, 25 (01) :79-80

[8] Prevalence of Neisseria meningitidis carriers in the school population of Catalonia, Spain [J].

Domínguez, A ;

Cardeñosa, N ;

Izquierdo, C ;

Sánchez, F ;

Margall, N ;

Vázquez, JA ;

Salleras, L .

EPIDEMIOLOGY AND INFECTION, 2001, 127 (03) :425-433

[9]

FINNE J, 1983, LANCET, V2, P355

[10] Development of vaccines against meningococcal disease [J].

Jódar, L ;

Feavers, IM ;

Salisbury, D ;

Granoff, DM .

LANCET, 2002, 359 (9316) :1499-1508

← 1 2 3 4 →